Two weeks after the subcutaneous injection, we found that the tumours formed in the pcDNA‐SLC25A5‐AS1 transfected group had smaller tumour size than those in vector control group (Figure 4A,B). This evidence concerns the gene SLC25A5 and neoplasm.